PI3K and PLCgamma play a central role in experimental PVR

Yasushi Ikuno1, Fee-Lai Leong, Andrius Kazlauskas

  • 1Schepens Eye Research Institute, Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts 02114, USA.

Abstract

Insights

Phosphoinositide 3-kinase (PI3K) and phospholipase C (PLC)-gamma are key downstream signaling enzymes required for platelet-derived growth factor (PDGF)-alpha receptor (alphaPDGFR) to mediate proliferative vitreoretinopathy (PVR). These findings clarify PVR pathogenesis.

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Molecular Biology

Background:

  • Proliferative vitreoretinopathy (PVR) is a severe complication of retinal detachment.
  • Platelet-derived growth factor (PDGF)-alpha receptor (alphaPDGFR) signaling is implicated in PVR development.
  • The specific downstream signaling pathways activated by alphaPDGFR in PVR remain incompletely understood.

Purpose of the Study:

  • To identify the critical signaling enzymes downstream of alphaPDGFR that mediate experimental PVR.
  • To elucidate the molecular mechanisms by which alphaPDGFR contributes to PVR.

Main Methods:

  • Generation and characterization of cell lines expressing alphaPDGFR signaling mutants.
  • Utilizing a rabbit model of experimental PVR.
  • Employing an in vitro collagen type I contraction assay to assess cellular function.

Main Results:

  • Phosphoinositide 3-kinase (PI3K) was identified as a required signaling enzyme for alphaPDGFR-mediated PVR.
  • Phospholipase C (PLC)-gamma also plays a role, though to a lesser extent than PI3K.
  • Cell lines with potent PVR-inducing capacity showed strong activity in the in vitro collagen contraction assay.

Conclusions:

  • PI3K and PLCgamma are essential downstream effectors of alphaPDGFR in the context of experimental PVR.
  • These signaling enzymes are crucial for cellular responses contributing to PVR, including chemotaxis, proliferation, extracellular matrix production, and contraction.

Related Concept Videos

Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...